NDC properties for NDC 9 49502-416
NDC item 49502041602
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-02 |
| NDC Item | 49502041602 |
| packaging | 2 TRAY in 1 KIT (49502-416-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-480-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-481-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | COMPLETED |
NDC item 49502041606
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-06 |
| NDC Item | 49502041606 |
| BLA | BLA761154 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | COMPLETED |
NDC item 51407083402
| NDC 9 | 51407-834 |
|---|---|
| NDC 10 | 51407-834-02 |
| NDC Item | 51407083402 |
| packaging | 2 TRAY in 1 KIT (51407-834-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (51407-844-02) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (51407-845-02) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-07-06 |
| Marketing status | ACTIVE |
NDC item 51407084402
| NDC 9 | 51407-844 |
|---|---|
| NDC 10 | 51407-844-02 |
| NDC Item | 51407084402 |
| packaging | 1 in 1 TRAY |
| packaging | 2 in 1 KIT |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
NDC item 83257002232
| NDC 9 | 83257-022 |
|---|---|
| NDC 10 | 83257-022-32 |
| NDC Item | 83257002232 |
| packaging | 2 TRAY in 1 KIT (83257-022-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |